KHIDI and KPMA jointly holding a forum for clinical studies.

Published: 2005-06-24 06:57:00

Updated: 2005-06-24 06:57:00

The Korea Health Industry Development Institute (KHIDI) and the Korea Pharmaceutical Manufacturers Association (KPMA) announced jointly to hold the 57th Health Industry Development Forum under the main topic of "Commercialization of Clinical Studies for the New Drug Development" at 2 p.m. June 24...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK